Phil Santangelo has developed a treatment for dengue virus using mRNA and CRISPR technology. Phil Santangelo has led development of a new treatment for dengue virus, using mRNA and CRISPR technology. ...

Tampa, FL, USA – The Global Virus Network (GVN), a coalition of leading human and animal virologists from 80+ Centers of Excellence and Affiliates in more than 40 countries dedicated to advancing ...

The EMA approved Moderna's mRNA COVID-19 and flu vaccine, but US political battles and funding cuts threaten the future of mRNA vaccine innovation. Talha Burki reports.

The Australia mRNA therapeutics market offers significant growth potential, driven by government support, technological ...

The Global Virus Network (GVN), a coalition of leading human and animal virologists from 80+ Centers of Excellence and Affiliates in more than 40 countries dedicated to advancing pandemic preparedness ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent and ...

mRNA-1345 is an investigational RSV vaccine that consists of a single mRNA sequence encoding for a stabilized prefusion F glycoprotein. The vaccine uses the same lipid nanoparticles (LNPs) as in the ...

Researchers at Aarhus University have built a DNA nanostructure shaped like a bacteriophage needle that can recognize ...

Please provide your email address to receive an email when new articles are posted on . There are now three FDA approved RSV vaccines. This marks the first mRNA vaccine approved by the FDA for the ...

A consortium including Korea Disease Control and Prevention Agency (KDCA), International Vaccine Institute (IVI), ST Pharm Co. Ltd. and Seoul National University (SNU) is joining forces with CEPI to ...